United Kingdom (UK) Genome Editing Market (2025-2031) | Forecast, Share, Competitive Landscape, Size & Revenue, Growth, Value, Outlook, Industry, Segmentation, Companies, Analysis, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Genome Editing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Genome Editing Market - Industry Life Cycle

3.4 United Kingdom (UK) Genome Editing Market - Porter's Five Forces

3.5 United Kingdom (UK) Genome Editing Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United Kingdom (UK) Genome Editing Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United Kingdom (UK) Genome Editing Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development in the field of genome editing

4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for advanced genetic therapies

4.2.3 Technological advancements in genome editing tools and techniques

4.3 Market Restraints

4.3.1 Stringent regulations and ethical concerns surrounding genome editing

4.3.2 High costs associated with genome editing procedures and tools

4.3.3 Limited awareness and understanding of genome editing among the general population

6.1 United Kingdom (UK) Genome Editing Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), 2021- 2031F

6.1.4 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Transcription Activator-like Effector Nuclease (TALEN), 2021- 2031F

6.1.5 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Zinc Finger Nuclease (ZFN), 2021- 2031F

6.1.6 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Other Technologies, 2021- 2031F

6.2 United Kingdom (UK) Genome Editing Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Cell Line Editing, 2021- 2031F

6.2.3 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Animal Genome Editing, 2021- 2031F

6.2.4 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Plant Genome Editing, 2021- 2031F

6.2.5 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Genome Editing Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Pharmaceutical Companies and Biotechnology Companies, 2021- 2031F

6.3.3 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Academics and Government Research Institutes, 2021- 2031F

6.3.4 United Kingdom (UK) Genome Editing Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F

7.1 United Kingdom (UK) Genome Editing Market Export to Major Countries

7.2 United Kingdom (UK) Genome Editing Market Imports from Major Countries

8.1 Number of clinical trials utilizing genome editing technologies in the UK

8.2 Adoption rate of genome editing techniques in healthcare institutions and research facilities

8.3 Number of partnerships and collaborations between academia, industry, and government in the genome editing sector

9.1 United Kingdom (UK) Genome Editing Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United Kingdom (UK) Genome Editing Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United Kingdom (UK) Genome Editing Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 United Kingdom (UK) Genome Editing Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Genome Editing Market Competitive Benchmarking, By Operating and Technical Parameters